#CanonInc

Resolved changes in representative directors effective March 27, 2026. Fujio Mitarai is scheduled to become Chairman CEO, and Kazuto Ogawa is scheduled to assume the position of President COO.

Canon Inc. has established a share buyback program from January 30, 2026, to January 29, 2027, with an upper limit of 54 million shares and a total amount capped at 200 billion yen.

Canon Inc. acquired 13,470,819 shares of Canon Electronics Inc. at ¥3,650 per share through a tender offer, raising its voting rights ownership ratio from 55.01% to 87.94% (ended January 19, 2026).

Canon Inc. has resolved to succeed part of Canon Medical Systems Corporation’s business through a simplified absorption-type company split, with the effective date set for April 1, 2026, aiming at business structural reform and strengthening organizational framework.

Canon Inc. has decided to voluntarily apply IFRS to its consolidated financial statements and consolidated documents from the first quarter of fiscal 2027.